AAEI is spotlighting members who are helping lead the Association on key issues, initiatives and projects. This week, the spotlight is on Guido Wiekert of Novartis Pharmaceutical Corporation.

Guido is Novartis’s primary contact for AAEI. Novartis a Swiss multinational pharmaceutical corporation based in Basel, Switzerland and Cambridge, MA. Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. Its work includes innovative medicines, including cardiovascular, hematological, and immunological therapeutic areas.

Guido is Novartis’s Associate Director Regulatory Environment. The company has been an AAEI member since 2014.